Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates

Clinical and Vaccine Immunology

Volumn 17, Issue 10, 2010, Pages 1631-1638

  Muerhoff, A Scott ^a   Birkenmeyer, Larry G ^a   Coffey, Ruthie ^a   Dille, Bruce J ^a   Barnwell, John W ^b   Collins, William E ^b   Sullivan, Joann S ^b   Dawson, George J ^a   Desai, Suresh M ^a  

^a ABBOTT DIAGNOSTICS   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 1 P19 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMPANZEE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; MALARIA; MEROZOITE SURFACE PROTEIN 1; PAN TROGLODYTES; PARASITOLOGY; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PLATYRRHINI; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 77957886548     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00196-10     Document Type: Article

References (50)

1. Achtman, A. H., P. C. Bull, R. Stephens, and J. Langhorne. 2005. Longevity of the immune response and memory to blood-stage malaria infection. Curr. Top. Microbiol. Immunol. 297:71-102.
2. Birkenmeyer, L., A. S. Muerhoff, G. Dawson, and S. M. Desai. 2010. Isolation and characterization of the MSP1 genes of Plasmodium malariae and Plasmodium ovale. Am. J. Trop. Med. Hyg. 82:996-1003.
3. Bolling, T. J., and W. Mandecki. 1990. An Escherichia coli expression vector for high-level production of heterologous proteins in fusion with CMP-KDO synthetase. Biotechniques 8:488-492.
4. Bruneel, F., M. Thellier, O. Eloy, D. Mazier, G. Boulard, M. Danis, and J. P. Bedos. 2004. Transfusion-transmitted malaria. Intensive Care Med. 30:1851-1852.
5. Coffey, R., L. Birkenmeyer, B. Dille, A. Haller, D. Mbanya, L. Kaptue, G. Schochetman, G. Dawson, S. Desai, and A. S. Muerhoff. 2008. Seroprevalence of Plasmodium falciparum, vivax, malariae and ovale antibodies among blood donors from Cameroon, abstr. 962. Abstr. 57th Annu. Meet. Am. Soc. Trop. Med. Hyg., New Orleans, LA.
6. Collins, W. E., G. M. Jeffery, and J. C. Skinner. 1964. Fluorescent antibody studies in human malaria. II. Development and persistence of antibodies to Plasmodium falciparum. Am. J. Trop. Med. Hyg. 13:256-260.
7. Collins, W. E., G. M. Jeffery, and J. C. Skinner. 1964. Fluorescent antibody studies in human malaria. III. Development of antibodies to Plasmodium falciparum in semi-immune patients. Am. J. Trop. Med. Hyg. 13:777-782.
8. Collins, W. E., G. M. Jeffery, and J. C. Skinner. 1964. Fluorescent antibody studies in human malaria. I. Development of antibodies to Plasmodium malariae. Am. J. Trop. Med. Hyg. 13:1-5.
9. Collins, W. E., J. C. Skinner, and G. M. Jeffery. 1968. Studies on the persistence of malarial antibody response. Am. J. Epidemiol. 87:592-598.
10. Cooper, J. A. 1993. Merozoite surface antigen-I of Plasmodium. Parasitol. Today 9:50-54.
11. Cox-Singh, J., T. M. Davis, K. S. Lee, S. S. Shamsul, A. Matusop, S. Ratnam, H. A. Rahman, D. J. Conway, and B. Singh. 2008. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin. Infect. Dis. 46:165-171.
12. Cox-Singh, J., and B. Singh. 2008. Knowlesi malaria: newly emergent and of public health importance? Trends Parasitol. 24:406-410.
13. Doderer, C., A. Heschung, P. Guntz, J. P. Cazenave, Y. Hansmann, A. Senegas, A. W. Pfaff, T. Abdelrahman, and E. Candolfi. 2007. A new ELISA kit which uses a combination of Plasmodium falciparum extract and recombinant Plasmodium vivax antigens as an alternative to IFAT for detection of malaria antibodies. Malar. J. 6:19.
14. Drakeley, C. J., P. H. Corran, P. G. Coleman, J. E. Tongren, S. L. McDonald, I. Carneiro, R. Malima, J. Lusingu, A. Manjurano, W. M. Nkya, M. M. Lemnge, J. Cox, H. Reyburn, and E. M. Riley. 2005. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc. Natl. Acad. Sci. U. S. A. 102:5108-5113.
15. Egan, A. F., M. J. Blackman, and D. C. Kaslow. 2000. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys. Infect. Immun. 68:1418-1427.
16. Elghouzzi, M. H., A. Senegas, T. Steinmetz, P. Guntz, V. Barlet, A. Assal, P. Gallian, P. Volle, C. Chuteau, M. Beolet, S. Berrebi, D. Filisetti, C. Doderer, T. Abdelrahman, and E. Candolfi. 2008. Multicentric evaluation of the DiaMed enzyme-linked immunosorbent assay malaria antibody test for screening of blood donors for malaria. Vox Sang. 94:33-40.
17. Eliades, M. J., S. Shah, P. Nguyen-Dinh, R. D. Newman, A. M. Barber, J. M. Roberts, S. Mali, M. E. Parise, and R. Steketee. 2005. Malaria surveillance - United States, 2003. MMWR Surveill. Summ. 54:25-40.
18. Faber, B. W., E. J. Remarque, W. D. Morgan, C. H. Kocken, A. A. Holder, and A. W. Thomas. 2007. Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1. Infect. Immun. 75:5947-5955.
19. Frey-Wettstein, M., A. Maier, K. Markwalder, and U. Munch. 2001. A case of transfusion transmitted malaria in Switzerland. Swiss Med. Wkly. 131:320.
20. Garraud, O., A. Assal, B. Pelletier, B. Danic, A. Kerleguer, B. David, M. Joussemet, and P. de Micco. 2008. Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang. 95:226-231.
21. Jongwutiwes, S., C. Putaporntip, T. Iwasaki, T. Sata, and H. Kanbara. 2004. Naturally acquired Plasmodium knowlesi malaria in human, Thailand. Emerg. Infect. Dis. 10:2211-2213.
22. Kim, S., H. J. Ahn, T. S. Kim, and H. W. Nam. 2003. ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas. Korean J. Parasitol. 41:203-207.
23. Kitchen, A. D., J. A. Barbara, and P. E. Hewitt. 2005. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang. 89:77-80.
24. Kitchen, A. D., and P. L. Chiodini. 2006. Malaria and blood transfusion. Vox Sang. 90:77-84.
25. Kitchen, A. D., P. H. Lowe, K. Lalloo, and P. L. Chiodini. 2004. Evaluation of a malarial antibody assay for use in the screening of blood and tissue products for clinical use. Vox Sang. 87:150-155.
26. Kumar, S., A. Yadava, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
27. Leiby, D., M. Nguyen, T. Goff, and J. Gibble. 2009. Shifting the focus of malaria deferrals: time for a new paradigm. Vox Sang. 96:38.
28. Leiby, D. A. 2007. Making sense of malaria. Transfusion 47:1573-1577.
29. Leiby, D. A., M. L. Nguyen, and E. P. Notari. 2008. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 48:2222-2228.
30. Lim, H. S., and H. S. Kim. 2001. Evaluation of diagnostic methods of re-emerging malaria in Korean patients. Yonsei Med. J. 42:84-90.
31. Luchavez, J., F. Espino, P. Curameng, R. Espina, D. Bell, P. Chiodini, D. Nolder, C. Sutherland, K. S. Lee, and B. Singh. 2008. Human Infections with Plasmodium knowlesi, the Philippines. Emerg. Infect. Dis. 14:811-813.
32. Mertens, G., T. Vervoort, S. Heylen, and L. Muylle. 1999. Malaria antibody ELISA insufficiently sensitive for blood donor screening. Vox Sang. 77:237-238.
33. Morais, C. G., I. S. Soares, L. H. Carvalho, C. J. Fontes, A. U. Krettli, and E. M. Braga. 2006. Antibodies to Plasmodium vivax apical membrane antigen 1: persistence and correlation with malaria transmission intensity. Am. J. Trop. Med. Hyg. 75:582-587.
34. Morais, C. G., I. S. Soares, L. H. Carvalho, C. J. Fontes, A. U. Krettli, and E. M. Braga. 2005. IgG isotype to C-terminal 19 kDa of Plasmodium vivax merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil. Parasitol. Res. 95:420-426.
35. Mühlberger, N., T. Jelinek, J. Gascon, M. Probst, T. Zoller, M. Schunk, J. Beran, I. Gjorup, R. H. Behrens, J. Clerinx, A. Bjorkman, P. McWhinney, A. Matteelli, R. Lopez-Velez, Z. Bisoffi, U. Hellgren, S. Puente, M. L. Schmid, B. Myrvang, M. L. Holthoff-Stich, H. Laferl, C. Hatz, H. Kollaritsch, A. Kapaun, J. Knobloch, J. Iversen, A. Kotlowski, D. J. Malvy, P. Kern, G. Fry, H. Siikamaki, M. H. Schulze, G. Soula, M. Paul, J. Gomez i Prat, V. Lehmann, O. Bouchaud, S. da Cunha, J. Atouguia, and G. Boecken. 2004. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar. J. 3:5.
36. Mungai, M., G. Tegtmeier, M. Chamberland, and M. Parise. 2001. Transfusion-transmitted malaria in the United States from 1963 through 1999. N. Engl. J. Med. 344:1973-1978.
37. Ng, O. T., E. E. Ooi, C. C. Lee, P. J. Lee, L. C. Ng, S. W. Pei, T. M. Tu, J. P. Loh, and Y. S. Leo. 2008. Naturally acquired human Plasmodium knowlesi infection, Singapore. Emerg. Infect. Dis. 14:814-816.
38. Oh, J. S., J. S. Kim, C. H. Lee, D. H. Nam, S. H. Kim, D. W. Park, C. K. Lee, C. S. Lim, and G. H. Park. 2008. Evaluation of a malaria antibody enzyme immunoassay for use in blood screening. Mem. Inst. Oswaldo Cruz 103:75-78.
39. Prudêncio, M., A. Rodriguez, and M. M. Mota. 2006. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 4:849-856.
40. Rodrigues, M. H., M. G. Cunha, R. L. Machado, O. C. Ferreira, Jr., M. M. Rodrigues, and I. S. Soares. 2003. Serological detection of Plasmodium vivax malaria using recombinant proteins corresponding to the 19-kDa C-terminal region of the merozoite surface protein-1. Malar. J. 2:39.
41. Rosa, D. S., F. Tzelepis, M. G. Cunha, I. S. Soares, and M. M. Rodrigues. 2004. The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate. Immunol. Lett. 92:259-268.
42. Seed, C. R., A. Cheng, T. M. Davis, W. V. Bolton, A. J. Keller, A. Kitchen, and T. J. Cobain. 2005. The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria. Vox Sang. 88:98-106.
43. Seed, C. R., A. Kitchen, and T. M. Davis. 2005. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus. Med. Rev. 19:229-240.
44. She, R. C., M. L. Rawlins, R. Mohl, S. L. Perkins, H. R. Hill, and C. M. Litwin. 2007. Comparison of immunofluorescence antibody testing and two enzyme immunoassays in the serologic diagnosis of malaria. J. Travel Med. 14:105-111.
45. Siddiqui, W. A., L. Q. Tam, K. J. Kramer, G. S. Hui, S. E. Case, K. M. Yamaga, S. P. Chang, E. B. Chan, and S. C. Kan. 1987. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. U. S. A. 84:3014-3018.
46. Singh, A. P., C. A. Buscaglia, Q. Wang, A. Levay, D. R. Nussenzweig, J. R. Walker, E. A. Winzeler, H. Fujii, B. M. Fontoura, and V. Nussenzweig. 2007. Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 131:492-504.
47. Srivastava, I. K., M. Schmidt, M. Grall, S. Yerly, A. M. Garcia, M. Bouvier, B. Takacs, H. Dobeli, and L. H. Perrin. 1991. Comparative evaluation of an ELISA based on recombinant polypeptides and IFA for serology of malaria. J. Trop. Med. Hyg. 94:189-194.
48. Stowers, A. W., V. Cioce, R. L. Shimp, M. Lawson, G. Hui, O. Muratova, D. C. Kaslow, R. Robinson, C. A. Long, and L. H. Miller. 2001. Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial. Infect. Immun. 69:1536-1546.
49. Vinetz, J. M., J. Li, T. F. McCutchan, and D. C. Kaslow. 1998. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N. Engl. J. Med. 338:367-371.
50. WHO. 2005, posting date. Malaria world report: World Health Organization and UNICEF. World Health Organization, Geneva, Switzerland. http://www. rollbackmalaria.org/wmr2005/index.html.